Browse
Browse
Home
People
Organizations
Research
Events
Capability Map
Phase Ib/II, open label, multicenter study of intratumoral SD-101 in combination with pembrolizumab in anti-PD-1 treatment naïve patients with recurrent or metastatic head and neck squamous cell carcinoma (HNSCC)
Academic Article
Overview
Identity
Additional Document Info
Overview
Authors
Lisle Nabell M.D.
Published In
Annals of Oncology
Journal
Identity
Digital Object Identifier (doi)
10.1093/annonc/mdy287.006
Additional Document Info
Author List
Cohen EEW; Algazi A; Laux D; Wong DJ; Amin A; Nabell L; Chisamore M; Gamelin E; Janssen R; Bishnoi S
Start Page
viii375
Volume
29